Article info
PDFReview
Genetic testing and reproductive choice in neurological disorders
- Correspondence to Mary Porteous, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital Campus, Edinburgh, EH4 2XU, Scotland, UK; Mary.Porteous{at}ed.ac.uk
Citation
Genetic testing and reproductive choice in neurological disorders
Publication history
- Accepted April 11, 2017
- First published May 16, 2017.
Online issue publication
November 24, 2017
Article Versions
- Previous version (24 November 2017).
- Previous version (24 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Huntington’s disease
- Genetic testing in motor neurone disease
- Presymptomatic testing in myotonic dystrophy: genetic counselling approaches
- Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?
- Paradox of a better test for Huntington's disease
- Primary prevention of neurological illness early in life
- Genetic counselling in ALS: facts, uncertainties and clinical suggestions
- Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severities
- Eight years' experience of direct molecular testing for myotonic dystrophy in Wales
- The right not to know and preimplantation genetic diagnosis for Huntington’s disease